Did you know?
ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.
Free Newsletter
Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!
Free Report
Pipeline Has Quantity; But Quality?. More details...
Transforming Event For Antibiotics Company. More details...
CBT 200 Drops 13 Points. More details...
Both Have Thin Pipelines. More details...
After Slow Uptake And A Burst Of Activity, Another...
CBT 200 Climbs 20 Points. More details...
CBT 200 Drops 7 Points. More details...
CBT 200 Rises 35 Points. More details...
Companies Seek The Right Mix. More details...
CBT 200 Flat Ahead of Fed Announcement Tomorrow. More...
ChinaBio® News
Greg Scott Interviewed at BIO-Europe Spring
How to bring your China assets to China in 8 minutes
"Mr. Bio in China."
Mendelspod Interview
Multinational pharma held to a higher standard in China